,33,34 CCL5 has been shown to facilitate (CCR5-mediated) interactions in multiple inflammatory disorders, and both chemokines are suggested as targets for treating CRS, graft-versus-host disease, and rheumatoid arthritis among others.35 Here, CCR5 is linked to graft versus host disease.